Table 4.
Treatment of Patients with Metastatic Melanoma Using Tumor Infiltrating Lymphocytes
| Partial regression + complete regression | |||
|---|---|---|---|
| Total n | n | % | |
| No previous interleukin-2 therapy | 52 | 19 | 37 |
| Previous interleukin-2 therapy | 21 | 7 | 33 |
| Total | 73 | 26 | 36 |
Treatment of Patients with Metastatic Melanoma Using Tumor Infiltrating Lymphocytes
| Partial regression + complete regression | |||
|---|---|---|---|
| Total n | n | % | |
| No previous interleukin-2 therapy | 52 | 19 | 37 |
| Previous interleukin-2 therapy | 21 | 7 | 33 |
| Total | 73 | 26 | 36 |